Loading in 2 Seconds...
Loading in 2 Seconds...
\nGrowing Geriatric Population Base and Rising Incidences of Target Diseases the Major Drivers of Neurostimulation Devices market
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Neurostimulation Devices Market Share, Size, Analysis, Growth,
Trends and Forecasts to 2020 | Hexa Research
“Neurostimulation Devices Market, With CAGR Of
14.2% from 2013 to 2020, Set To Witness Robust
Growth, Emerging Economies Expected To
Generate Significant Demand”
A recent study by Hexa Research revealed that limited range of treatment choices relating to medical
conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key
drivers of the global Neurostimulation Devices Market. An upcoming application area is the use of
neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. The
neurostimulation devices market is benefitting from technological advancements like the transdermal
neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by
Medtronics, Inc. Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also
driving market growth. Accelerated demand for neurostimulation devices in the future years is expected to
result from untapped market opportunities in emerging economies of Asia as well as Latin America and the
growing number of externally funded clinical programs for development of new products.
Browse Details of Report @ - https://www.hexaresearch.com/research-report/neurostimulation-devices-
Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric
stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key
product segments in the neurostimulation devices market. Spinal cord stimulation devices, with a
contribution of more than half to the total revenues, were the dominant product segment in 2012.
Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed
more than 65% to the total demand that year. This was chiefly due to high incidence of conditions
characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices.
While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the
fastest in future. Fast-developing economies like India and China will result in the Asia Pacific
neurostimulation devices market growing at CAGR higher than 16% from 2013 to 2020.
Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive
manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability.
Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., and St. Jude Medical.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-
Table of Contents
Chapter 1. Executive Summary
1.1. Neurostimulation Devices – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Neurostimulation devices Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Neurostimulation devices Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Neurostimulation Devices - Company Market Share Analysis
2.7. Neurostimulation Devices Market PESTEL Analysis, 2012
Chapter 3. Neurostimulation Devices Product Outlook
3.1. Deep Brain Stimulation Device
3.2. Gastric Electric Stimulation Device
3.3. Spinal Cord Stimulation Device
3.4. Sacral Nerve Stimulation Device
3.5. Vagus Nerve Stimulation Device
Chapter 4. Neurostimulation Devices Application Outlook
4.1. Pain Management
4.3. Essential Tremor
4.4. Urinary and Fecal Incontinence
4.8. Parkinson's Disease
Chapter 5. Neurostimulation Devices Regional Outlook
5.1. North America
5.3. Asia Pacific
Chapter 6. Competitive Landscape
6.1. Revenue Analysis
6.2. Product Benchmarking
6.3. Strategic Development
Chapter 7. Methodology and Scope
7.1. Research Methodology
7.2. Research Scope & Assumption
7.3. List of Data Sources
Codman and Shurtleff Inc.
Integra Life Sciences
St. Jude Medical
Boston Scientific Corporation
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Felton Office Plaza
6265 Highway 9
Felton, California 95018
Read Our Latest Blogs: hexaresearch1.blogspot.com